Vom Labor zur Klinik: vollsynthetische Antitumor-Impfstoffe auf Kohlenhydratbasis
- 3 March 2000
- journal article
- research article
- Published by Wiley in Angewandte Chemie
- Vol. 112 (5) , 882-912
- https://doi.org/10.1002/(sici)1521-3757(20000303)112:5<882::aid-ange882>3.0.co;2-1
Abstract
No abstract availableKeywords
This publication has 106 references indexed in Scilit:
- A Broadly Applicable Method for the Efficient Synthesis of α-O-Linked Glycopeptides and Clustered Sialic Acid ResiduesJournal of the American Chemical Society, 1999
- A Fully Synthetic Globo H Carbohydrate Vaccine Induces a Focused Humoral Response in Prostate Cancer Patients: A Proof of PrincipleAngewandte Chemie International Edition in English, 1999
- Solid‐Phase Synthesis of a Tumor‐Associated Sialyl‐TN Antigen Glycopeptide with a Partial Sequence of the “Tandem Repeat” of the MUC‐1 MucinAngewandte Chemie International Edition in English, 1997
- Characterization of an Antigen That Is Recognized on a Melanoma Showing Partial HLA Loss by CTL Expressing an NK Inhibitory ReceptorImmunity, 1997
- Leukocyte adhesion: Two selectins converge on sulphateCurrent Biology, 1996
- A total synthesis of a stage specific pentasaccharide embryogenesis markerTetrahedron Letters, 1995
- The X-ray structure of an anti-tumour antibody in complex with antigenNature Structural & Molecular Biology, 1995
- Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvantCancer Immunology, Immunotherapy, 1993
- Synthesis of a Trifucosyl Ley Heptasaccharide Corresponding to a Tumor-Associated GlycolipidJournal of Carbohydrate Chemistry, 1992
- Fucosyl-GM1 — A ganglioside associated with small cell lung carcinomasGlycoconjugate Journal, 1984